BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34634798)

  • 1. Conducting tobacco industry informant interviews: lessons and implications for commercial determinants of health research.
    Watts C; Burton S; Freeman B
    Health Promot Int; 2022 Apr; 37(2):. PubMed ID: 34634798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'The last line of marketing': Covert tobacco marketing tactics as revealed by former tobacco industry employees.
    Watts C; Burton S; Freeman B
    Glob Public Health; 2021 Jul; 16(7):1000-1013. PubMed ID: 32946326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How tobacco companies use the revolving door between government and industry to influence policymaking: an Australian case study.
    Watts C; Jones M; Lindorff K; Freeman B
    Public Health Res Pract; 2023 Dec; 33(4):. PubMed ID: 37164761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco industry's 'behind the scenes' tactics in Singapore.
    van der Eijk Y; Tan GPP
    Tob Control; 2023 May; 32(3):280-286. PubMed ID: 34452987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco industry misappropriation of American Indian culture and traditional tobacco.
    D'Silva J; O'Gara E; Villaluz NT
    Tob Control; 2018 Jul; 27(e1):e57-e64. PubMed ID: 29459389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the tobacco industry documents for public health and policy.
    Bero L
    Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco industry interference with tobacco control policies in Poland: legal aspects and industry practices.
    Balwicki Ł; Stokłosa M; Balwicka-Szczyrba M; Tomczak W
    Tob Control; 2016 Sep; 25(5):521-6. PubMed ID: 26418616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The devil is in the detail: tobacco industry political influence in the Dutch implementation of the 2001 EU Tobacco Products Directive.
    Lie JL; Willemsen MC; de Vries NK; Fooks G
    Tob Control; 2016 Sep; 25(5):545-50. PubMed ID: 26349910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries.
    Charoenca N; Mock J; Kungskulniti N; Preechawong S; Kojetin N; Hamann SL
    Int J Environ Res Public Health; 2012 Apr; 9(4):1111-34. PubMed ID: 22690186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Conduct Store Observations of Tobacco Marketing and Products.
    Feld AL; Johnson TO; Byerly KW; Ribisl KM
    Prev Chronic Dis; 2016 Feb; 13():E25. PubMed ID: 26890408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Gone are the days of mass-media marketing plans and short term customer relationships": tobacco industry direct mail and database marketing strategies.
    Lewis MJ; Ling PM
    Tob Control; 2016 Jul; 25(4):430-6. PubMed ID: 26243810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaping industry participation standards in health organizations: an exploratory policy content analysis.
    Haklar I; Stephens J; Bowden J; Trigg J
    Health Promot Int; 2023 Dec; 38(6):. PubMed ID: 37943847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco-control policies in tobacco-growing states: where tobacco was king.
    Fallin A; Glantz SA
    Milbank Q; 2015 Jun; 93(2):319-58. PubMed ID: 26044632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power and Other Commercial Determinants of Health: An Empirical Study of the Australian Food, Alcohol, and Gambling Industries.
    de Lacy-Vawdon C; Vandenberg B; Livingstone C
    Int J Health Policy Manag; 2023; 12():7723. PubMed ID: 37579379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Playing hide-and-seek with the tobacco industry.
    LeGresley EM; Muggli ME; Hurt RD
    Nicotine Tob Res; 2005 Feb; 7(1):27-40. PubMed ID: 15804675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the long-term policy influence strategies of the tobacco industry: two contemporary case studies.
    Hird TR; Gallagher AWA; Evans-Reeves K; Zatoński M; Dance S; Diethelm PA; Edwards R; Gilmore AB
    Tob Control; 2022 Mar; 31(2):297-307. PubMed ID: 35241603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The WHO FCTC's lessons for addressing the commercial determinants of health.
    McHardy J
    Health Promot Int; 2021 Dec; 36(Supplement_1):i39-i52. PubMed ID: 34897446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco industry targeting of health-conscious youth with 'lighter' cigarettes: the case of Singapore.
    van der Eijk Y; Tan GPP
    Tob Control; 2021 Nov; 30(e1):e20-e26. PubMed ID: 33067408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.